ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105160 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chung-Pu Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter, Subfamily G, Member 2, Drug Resistance, Neoplasm, ErbB Receptors, Neoplasm Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of science and technology, Taiwan, Chang Gung Memorial Hospital, Taichung Veterans General Hospital.
Abstract (Originalsprache)
MTX-211 is a first-in-class dual inhibitor of epidermal growth factor receptor (EGFR) and phosphoinositide-3 kinase (PI3K) signaling pathways with a compelling pharmaceutical profile and could enhance the effectiveness of mitogen-activated protein kinase kinase (MEK) inhibitor therapy in colorectal tumors with KRAS mutations. However, the specific mechanisms contributing to the acquired resistance to MTX-211 in human cancers remain elusive. Here, we discovered that the overexpression of the ATP-binding cassette (ABC) drug transporter ABCG2, a prevalent mechanism associated with multidrug resistance (MDR), could diminish the effectiveness of MTX-211 in human cancer cells. We showed that the drug efflux activity of ABCG2 substantially decreased the intracellular accumulation of MTX-211 in cancer cells. As a result, the cytotoxicity and effectiveness of MTX-211 in suppressing the activation of the EGFR and PI3K pathways were significantly attenuated in cancer cells overexpressing ABCG2. Moreover, the enhancement of the MTX-211-stimulated ATPase activity of ABCG2 and the computational molecular docking analysis illustrating the binding of MTX-211 to the substrate-binding sites of ABCG2 offered a further indication for the interaction between MTX-211 and ABCG2. In summary, our findings indicate that MTX-211 acts as a substrate for ABCG2, underscoring the involvement of ABCG2 in the emergence of resistance to MTX-211. This finding carries clinical implications and merits further exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- Department of Physiology and Pharmacology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei 10507, Taiwan.
- Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Chemistry, Tunghai University, Taichung 40704, Taiwan.
ORCID-Profile: Chung-Pu Wu, Megumi Murakami, Yu-Shan Wu, Jau-Song Yu, Suresh V Ambudkar
Förderung
- Ministry of science and technology, Taiwan
- Chang Gung Memorial Hospital
- Taichung Veterans General Hospital
- NIH HHS
- National Institutes of Health, National Cancer Institute, Center for Cancer Research
Zitieren
APA
Wu, C. P., Hung, C. Y., Murakami, M., Wu, Y. S., Chu, Y. H., Huang, Y. H., Yu, J. S., & Ambudkar, S. V. (2024). ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105160
Vancouver
Wu CP, Hung CY, Murakami M, Wu YS, Chu YH, Huang YH, et al. ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105160
BibTeX
@article{Wu2024,
author = {Wu, Chung-Pu and Hung, Cheng-Yu and Murakami, Megumi and Wu, Yu-Shan and Chu, Yi-Hsuan and Huang, Yang-Hui and Yu, Jau-Song and Ambudkar, Suresh V},
title = {ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105160}
}
EUVIMED